Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
| Image |  |
|---|---|
| Description | scientific article published on 27 September 2018 |
| Author/s |
author: Julio Delgado Laura Magnano Juan G Valero Miguel Alcoceba Ferran Nadeu Enrique Colado Carlos López Otín Elías Campo |
| Publication date | September 27, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |